Soticlestat, CAS [[1429505-03-2]]

Produktübersicht

• Artikelname: Soticlestat, CAS [[1429505-03-2]]
• Artikelnummer: BYT-ORB1298509
• Hersteller Artikelnummer: orb1298509
• Alternativnummer: BYT-ORB1298509-1, BYT-ORB1298509-1, BYT-ORB1298509-10, BYT-ORB1298509-100, BYT-ORB1298509-25, BYT-ORB1298509-5, BYT-ORB1298509-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: OV935, OV-935, OV 935, NMDA, inhibit, Inhibitor, epilepsy, cholesterol, CYPs, CYP46A1, Cytochrome P450, 24-hydroxylase, antiepileptic, Soticlestat, TAK935, TAK-935, TAK 935

Produktbeschreibung

Soticlestat (OV935) is a potent, selective, and orally bioavailable inhibitor of cholesterol 24-hydroxylase (CYP46A1). It is a research compound for investigating epilepsy syndromes, with studies demonstrating activity in both in vitro enzymatic assays and in vivo rodent seizure models.

Produkteigenschaften

• Molekulargewicht: 373.45
• Reinheit: 99.95% (May vary between batches)
• CAS Nummer: [1429505-03-2]
• Formel: C23H23N3O2
• Target-Kategorie: Cytochromes P450

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (10.71 mM),DMSO:100 mg/mL (267.77 mM)